GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (XSWX:STMN) » Definitions » PE Ratio

Straumann Holding AG (XSWX:STMN) PE Ratio

: 91.07 (As of Today)
View and export this data going back to 2001. Start your Free Trial

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-04-16), Straumann Holding AG's share price is CHF140.25. Straumann Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF1.54. Therefore, Straumann Holding AG's PE Ratio for today is 91.07.


The historical rank and industry rank for Straumann Holding AG's PE Ratio or its related term are showing as below:

XSWX:STMN' s PE Ratio Range Over the Past 10 Years
Min: 19.9   Med: 47.01   Max: 357.77
Current: 91.07


During the past 13 years, the highest PE Ratio of Straumann Holding AG was 357.77. The lowest was 19.90. And the median was 47.01.


XSWX:STMN's PE Ratio is ranked worse than
89.22% of 408 companies
in the Medical Devices & Instruments industry
Industry Median: 26.575 vs XSWX:STMN: 91.07

Straumann Holding AG's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was CHF0.25. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF1.54.

As of today (2024-04-16), Straumann Holding AG's share price is CHF140.25. Straumann Holding AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.76. Therefore, Straumann Holding AG's PE Ratio without NRI for today is 50.82.

During the past 13 years, Straumann Holding AG's highest PE Ratio without NRI was 126.86. The lowest was 19.94. And the median was 43.06.

Straumann Holding AG's EPS without NRI for the six months ended in Dec. 2023 was CHF1.33. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.76.

During the past 12 months, Straumann Holding AG's average EPS without NRI Growth Rate was -8.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 19.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 16.90% per year.

During the past 13 years, Straumann Holding AG's highest 3-Year average EPS without NRI Growth Rate was 109.80% per year. The lowest was -60.10% per year. And the median was 19.50% per year.

Straumann Holding AG's EPS (Basic) for the six months ended in Dec. 2023 was CHF0.25. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF1.54.


Straumann Holding AG PE Ratio Historical Data

The historical data trend for Straumann Holding AG's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.35 180.02 78.10 38.82 88.05

Straumann Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.10 At Loss 38.82 At Loss 88.05

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Straumann Holding AG PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's PE Ratio falls into.



Straumann Holding AG PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Straumann Holding AG's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=140.25/1.540
=91.07

Straumann Holding AG's Share Price of today is CHF140.25.
For company reported semi-annually, Straumann Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF1.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio or PE Ratio (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Straumann Holding AG  (XSWX:STMN) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Straumann Holding AG PE Ratio Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Straumann Holding AG (XSWX:STMN) Business Description

Traded in Other Exchanges
Address
Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (XSWX:STMN) Headlines

No Headlines